The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…
HOME > BUSINESS
BUSINESS
- Ethical Drug Sales Down 0.3% in June: Crecon Report
August 8, 2012
- Hospira Files Additional Indication for Precedex for Non-Intubated Patients
August 8, 2012
- Daiichi Sankyo to Strengthen Cardiovascular Field by Comarketing Diabetes Treatments, Focusing on SGLT-2 Inhibitor
August 8, 2012
- 6 Listed Wholesalers Post Low Price Settlement Rates as of End-June, Showing Declines Compared to 2 Years Earlier
August 7, 2012
- Astellas to Close US Subsidiary for Urology Research
August 7, 2012
- Fuji Pharma to Acquire Thailand’s Largest Contract Manufacturer, to Make It Base of Overseas Operations
August 7, 2012
- Japan BCG Laboratory, Nippon Kayaku to Copromote Immunobladder
August 7, 2012
- Astellas to “Seek Every Opportunity” for Domestic Vaccine Business, Including Alliances with Foreign Companies
August 6, 2012
- Astellas’s Sales Down 3.3% in April-June Due to Competition with Generics
August 6, 2012
- Takeda to Exclusively Distribute 7 J&J OTC Brands in Japan
August 6, 2012
- Eisai’s April-June Sales, Profits Show Double-Digit Decrease by NHI Price Reduction of Aricept
August 6, 2012
- Sanofi Pasteur Not Planning to Follow Request to Cut IPV Price: President Triomphe
August 3, 2012
- Eisai: Domestic Sales of Aricept Down 6% on Volume Basis, to Target 90 Billion Yen through Patient Campaign
August 3, 2012
- Shionogi Files NDA for Lipodystrophy Treatment based on Data from Investigator-Initiated Trial
August 3, 2012
- DSP to Establish Sales Force for Anticancer Drugs in North America
August 3, 2012
- Rebamipide Is Most Frequently Prescribed Drug by Generic Name: Apollo Medical Survey
August 3, 2012
- Daiichi Sankyo: April-June Nexium Sales 6% of Full-Year Target, Set to Boost Promotion after Lifting of Long-Term Prescription Ban
August 2, 2012
- Otsuka Files for Additional Indication for Samsca for Fluid Retention with Liver Cirrhosis
August 2, 2012
- BMKK, Pfizer Promote Disease Education on Chronic Hepatitis B
August 2, 2012
- Shionogi Launches Endoxan Powder Aimed at Pediatric Patients
August 2, 2012
ページ
Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…
Novartis’ Pluvicto (lutetium vipivotide tetraxetan (177Lu)) won reimbursement listing in Japan in November as a radioligand therapy (RLT) for PSMA-positive…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…